Cole Pharmaceuticals Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Latest Deal Amount
  • $1.62M

  • Investors
  • 1

Cole Pharmaceuticals General Information

Description

Operator of a specialty pharmaceutical company primarily focused on areas like bone health, immunity, and cough and cold. The company is currently established in its home market, Belgium, and is expanding internationally through distributors, it is actively pursuing growth by entering underserved and new markets, with a focus on optimizing therapy outcomes, enabling patients to access products that are either based on proprietary systems or are specifically formulated.

Contact Information

Website
www.colepharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Axis Parc - Batiment Dumont 7
  • Rue André Dumont 7, Mont-Saint-Guibert
  • 1435 Louvain-la-Neuve
  • Belgium
+32 010
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Axis Parc - Batiment Dumont 7
  • Rue André Dumont 7, Mont-Saint-Guibert
  • 1435 Louvain-la-Neuve
  • Belgium
+32 010

Cole Pharmaceuticals Timeline

2022202320242025
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cole Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC $1.62M Cancelled Generating Revenue/Not Profitable
3. Later Stage VC 31-Aug-2023 Completed Generating Revenue/Not Profitable
2. Later Stage VC 10-Jun-2022 $1.15M $1.64M Completed Generating Revenue/Not Profitable
1. Equity Crowdfunding 10-Jan-2020 $488K $488K Completed Startup
To view Cole Pharmaceuticals’s complete valuation and funding history, request access »

Cole Pharmaceuticals Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class D
Class C
Class C 646,704 $1.83 $1.83 1x $1.83 26.37%
Ordinary 438,400 $1.09 $1.09 1x $1.09 17.88%
To view Cole Pharmaceuticals’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Cole Pharmaceuticals Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Cole Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3922237-A1 Orodispersible composition in the form of a dispersible tablet/in the form of an orodispersible tablet comprising at least one vitamin as an active substance Pending 11-Jun-2020

Cole Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Spreds VC-Backed Company Minority
To view Cole Pharmaceuticals’s complete investors history, request access »

Ready to get started?

Request a free trial

Cole Pharmaceuticals FAQs

  • When was Cole Pharmaceuticals founded?

    Cole Pharmaceuticals was founded in 2017.

  • Where is Cole Pharmaceuticals headquartered?

    Cole Pharmaceuticals is headquartered in Louvain-la-Neuve, Belgium.

  • What industry is Cole Pharmaceuticals in?

    Cole Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Cole Pharmaceuticals a private or public company?

    Cole Pharmaceuticals is a Private company.

  • What is the current valuation of Cole Pharmaceuticals?

    The current valuation of Cole Pharmaceuticals is .

  • What is Cole Pharmaceuticals’s current revenue?

    The current revenue for Cole Pharmaceuticals is .

  • How much funding has Cole Pharmaceuticals raised over time?

    Cole Pharmaceuticals has raised $2.28M.

  • Who are Cole Pharmaceuticals’s investors?

    Spreds has invested in Cole Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »